Medical Updates

Delgocitinib Ointment, A Promising Therapeutic Option for Atopic Dermatitis

Delgocitinib ointment is a novel topical Janus kinase inhibitor for the treatment of   atopic dermatitis (AD).  It has demonstrated potential...

27 Feb, 2020

 
Email this page
Lipid Profile Abnormalities in Patients with Acne Vulgaris

Acne is a common skin disease resulting from a complex interaction of various pathogenetic factors. There is growing evidence that indicates that...

20 Feb, 2020

 
Email this page
Efficacy and Safety of Once-Daily Tazarotene 0.045% Lotion in Moderate-to-Severe Acne Vulgaris in Adult Males

Acne is likely less common in adult men because of the declining rate of sebum secretion observed with increasing age. However, it can be more...

20 Feb, 2020

 
Email this page
Ferulic Acid 12% Peel, Safe and Effective Treatment for Periorbital Hyperpigmentation in Indian Patients

Treatment of periorbital hyperpigmentation (POH) includes chemical peels and other depigmenting agents. In a recent open-label, prospective study,...

22 Jan, 2020

 
Email this page

Slide Library

Luliconazole

This presentation includes information pertaining to the molecule Luliconazole, which is a novel topical imidazole antifungal agent used for the...

 
Email this page
Dapsone 5% Gel (Acnedap Gel)

Dapsone is a synthetic sulfone used to treat inflammatory cutaneous disorders. Topical dapsone gel 5% is approved by US FDA for the treatment of...

 
Email this page
Lumacip Plus

Cream containing 4% hydroquinone, 0.05% tretinoin and 0.01% fluocinolone acetonide is the approved combination for treatment of moderate to severe...

 
Email this page
Sertaconazole (Sertacide)

Sertaconazole is a topical broad-spectrum antifungal for the treatment of superficial cutaneous and mucosal fungal infections. This slide set...

 
Email this page

Key Trials

Bilastine Significantly Reduces Pruritus in Chronic Spontaneous Urticaria and Other Skin Diseases

Treatment with bilastine was effective in relieving pruritus associated with urticaria and other skin diseases and was safe and well tolerated.  

LIBERATE Trial: Oral Apremilast, An Effective Therapeutic Option for the Treatment of Biologic-naive Patients Plaque Psoriasis

LIBERATE trial assessed the efficacy and safety of apremilast vs. placebo in biologic-naive patients with moderate-to-severe plaque psoriasis and...

Dapsone Gel 5% in Combination with Topical Retinoid/Benzoyl Peroxide for Treatment of Acne

This study evaluated safety and efficacy of dapsone gel 5%, in treatment of acne when used in combination with adapalene gel 0.1% or benzoyl...

Dapsone 5% Gel Monotherapy, A Better Option than Clindamycin 1% Gel Monotherapy for Treatment of Acne Vulgaris: Results from 12 weeks Comparative Study

Acne vulgaris is the most common skin disorders which dermatologist treat. There are a number of treatment modalities available for the treatment of...

Our Publications

Overview of VC X (Vitamin C + Vitamin E + Ferulic acid)

Presence of free radicals in the skin affect its cellular structures. It also depletes the natural reservoir of antioxidants in the skin which leads...

Valacyclovir: Clinical Studies on Herpes Labialis

Valacyclovir is a prodrug of acyclovir and has activity against herpes virus. This booklet highlights the clinical studies on the efficacy and...

Xgain Hair Serum: The Inside Story

Hair is an important component of body image and plays a significant role in self perception. Cosmetic practices such as combing, brushing, braiding...

Melasma and It’s Management: Keypoints

Melasma is the most common hyperpigmentation disorder affecting millions of people worldwide. This booklet includes few key points about melasma and...

Patient Education

Suncare Tips

Sun rays are harmful. Unprotected exposure to these rays can cause skin damage, eye damage, immune system suppression, and skin cancer. Here are a fe...

How does Finasteride Work?

This video-animation features the mechanism of action of Finasteride in the treatment of androgenic alopecia.

Poll

What percentage of chronic spontaneous urticaria patients do not respond to normal dosing of anti-histaminic drugs?
10-20%
20% (2 votes)
21-30%
30% (3 votes)
31-40%
20% (2 votes)
41-50%
10% (1 vote)
More than 50%
20% (2 votes)
Total votes: 10